These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 25620163
21. Universal vaginal applicator for the uniform distribution of vaginal gel and cream formulations: a magnetic resonance imaging study. Omar RF, Trottier S, Brousseau G, Ouellet C, Danylo A, Ong T, Bergeron MG. J Obstet Gynaecol Can; 2014 Jan; 36(1):42-50. PubMed ID: 24444286 [Abstract] [Full Text] [Related]
27. Workflow and efficiency in MRI-based high-dose-rate brachytherapy for cervical cancer in a high-volume brachytherapy center. Kim H, Houser CJ, Kalash R, Maceil CA, Palestra B, Malush D, Beriwal S. Brachytherapy; 2018 Nov; 17(5):753-760. PubMed ID: 29844009 [Abstract] [Full Text] [Related]
30. Dosimetric Comparison between Three-Dimensional Magnetic Resonance Imaging-Guided and Conventional Two-Dimensional Point A-Based Intracavitary Brachytherapy Planning for Cervical Cancer. Ren J, Yuan W, Wang R, Wang Q, Li Y, Xue C, Yan Y, Ma X, Tan L, Liu Z. PLoS One; 2016 Nov; 11(9):e0161932. PubMed ID: 27611853 [Abstract] [Full Text] [Related]
31. Factors associated with deformation accuracy and modes of failure for MRI-optimized cervical brachytherapy using deformable image registration. Dyer BA, Yuan Z, Qiu J, Benedict SH, Valicenti RK, Mayadev JS, Rong Y. Brachytherapy; 2019 Nov; 18(3):378-386. PubMed ID: 30745016 [Abstract] [Full Text] [Related]
32. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer employing MRI with a tandem/ring applicator in situ and virtual preplanning of the interstitial component. Fokdal L, Tanderup K, Hokland SB, Røhl L, Pedersen EM, Nielsen SK, Paludan M, Lindegaard JC. Radiother Oncol; 2013 Apr; 107(1):63-8. PubMed ID: 23452917 [Abstract] [Full Text] [Related]
33. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users. Nomden CN, de Leeuw AA, Van Limbergen E, de Brabandere M, Nulens A, Nout RA, Laman M, Ketelaars M, Lutgens L, Reniers B, Jürgenliemk-Schulz IM. Radiother Oncol; 2013 Apr; 107(1):82-7. PubMed ID: 23127774 [Abstract] [Full Text] [Related]
34. Determination of 3D dose distribution from intracavitary brachytherapy of cervical cancer by MRI of irradiated ferrous sulphate gel. Knutsen BH, Skretting A, Hellebust TP, Olsen DR. Radiother Oncol; 1997 May; 43(2):219-27. PubMed ID: 9192970 [Abstract] [Full Text] [Related]
39. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer. Assenholt MS, Petersen JB, Nielsen SK, Lindegaard JC, Tanderup K. Acta Oncol; 2008 May; 47(7):1337-43. PubMed ID: 18663651 [Abstract] [Full Text] [Related]
40. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):131-7. PubMed ID: 15850913 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]